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Toxicosis of Snake, Scorpion,




Toxicosis is a poisoning caused by venomous animals such as snake, scorpion,
honeybee, spider, and wasp. Their poisons contain amino acids, peptides, proteins,
enzymes, and metallic ions that are responsible for neurotoxicity, hemotoxicity,
and myotoxicity. Because of in vivo therapeutic challenges posed by toxicosis, there
is need for ideal therapeutic agents against envenomation caused by venomous
animals. Findings have shown that toxicosis could be treated symptomatically.
Snake and scorpion antivenins could be used for treatment of poisoning caused by
snake, scorpion, honeybee, spider, and wasp. The amount of antivenin is dependent
on the quantity of venom injected into the affected individuals. More so, symptom-
atic treatments are also done according to the systems affected. Hospitalization is
necessary for assessment of therapeutic success.
Keywords: toxicosis, snake, scorpion, toxin, antivenin, lethality, hemotoxicity,
neurotoxicity, myotoxicity, hospitalization
1. Introduction
Venomous animals such as snake, scorpion, honeybee, spider, and wasp constitute
very significant health hazard in the world. The snake venom contains many toxic
and non-toxic molecules [1]. Forty-seven out of 50 US States have venomous snakes.
Southwestern US are mostly affected. About 4700 venomous snakes bite human and
150,000 primarily dogs and cats are bitten by venomous snakes every year in the US,
with human mortality of 0.06% and that of dog is 1–30% [2]. Scorpionism is caused
by many poisonous scorpions including Tityus species endemic to Panama, whereas
Centruroides are endemic to Guatemala, Belize, El Salvador, Nicaragua, and Costa
Rica. They are wildly toxic via unchannel active toxins. In Panama, the incidence was
52 cases per 100,000 in 2007 and 28 deaths were recorded between 1998 and 2006,
respectively. Tityus species present in the Atlantic coast of Costa Rica is responsible
for fatalities in Panama. Tityus pachyurus [3] and Parabuthus granulatus are of the
most medical importance in the Western Cape of South Africa. P. transvaalicus
venom is used for production of P. granulatus venom [4]. About 200,000 cases of
scorpionism are reported in Mexico and cause 310 deaths every year and 20,000 out
of 38,068 affected persons were successfully treated using equine antiserum
(serotherapy) and no life was lost [5]. The first case of scorpionism was reported in
Canada in a 36 year old man in 1962. The rate of scorpionism in Amazon region of
Brazil is 8.14–273 cases per 100,000. Most species involved in envenomation belong
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to the genus of Tityus [6]. M. gibbosus is endemic to a small geographic area of Erbalj
on terra rossa soil [7]. The incidence of scorpion sting in Iran was 61.2 per 100,000
populations [8], as against 1.2 million people with estimated 3250 death per year. The
mean annual rate was 17.4 per woman population [9]. The highest rate of sting
occurred in Iran among individuals of 25- to 34-year-old [8]. The global mortality rate
was 10 per 1000 cases. Most of the stings were seen on lower limbs (58.6%) and
upper limbs (34.3%) during the hot season [10]. The scorpion that had envenomated
for the first time may have less toxic envenomation for the second time as reported in
the case of sting from Leiurus abdullahbayrami [11]. In India, envenomation was
more common in males than in females [12].
Honeybee (Apis mellifera) constitutes a significant nuisance and of medical impor-
tance in Africa, Europe and other parts of the world. Other subspecies are A. mellifera
carnica, A. mellifera ligustica, and A. mellifera scutellata [13]. Honeybee stings reported
in Ceara, Brazil showed 1307 cases affecting men between 20 and 29 years of age [14]
translating to 19 cases per 100,000 in Campina Grade [15]. Bee envenomation is a
problem in India, China, Latin America, Middle East, and North and South Africa
[16]. About 200 stings from Apis mellifera could cause envenoming syndrome in
children and elderly [17] as multiple stings, not increased venom potency or delivery
cause serious reactions [18]. Bee venoms differ in weight and concentrations of phos-
pholipase and melittin [19]. Unfortunately, no specific antivenom for bee envenom-
ation; hence, proper removal of stings, first aid treatment and chemotherapy should
be considered as medical emergency [20]. Administration of hydrocortisone, calcium,
analgesic, and 0.9% sodium chloride and application of ice to the site of stung preg-
nant woman resulted in recovery from the pain and the fetus was stable and delivered
3 months after treatment without sequela [21]. There are 42,473 species of spiders
grouped into 110 families (Platnick) [22].Hadronyche formidabilis andH. cerberea have
very high envenoming rates [23]. Black widow spider (Latrodectus mactans) and
brown recluse spider (Loxosceles reclusa) are of most concern [24]. In view of the
increased challenges and negligence of envenomation caused by venomous snake,
scorpion, spider, wasp, and bee, there is need for thorough search for their therapeutic
regimens with a view to having lasting solution against fatality.
2. Methodology
Literatures were searched on venomous snakes, scorpions, honeybees, spiders,
and wasps with an intent to identifying their toxicity potentials, epidemiology of
their toxicosis, signs of toxicity, treatment, and development of vaccines against
their venoms. Sought also are information on medicinal plants, phytochemicals and
other therapeutic agents, structures of some chemicals present in the venoms, and
their medical applications and medicinal uses. Mathematical formulas were also
derived for calculation of body weight, body surface area, packed cell volume,
hemoglobin, total blood volume, lost blood volume, median lethal dose (LD50),
median effective dose (ED50), number of bee stings, total dose of bee venom, and
relationship between renotoxicity and hemotoxicity.
3. Results
Findings have shown that venoms from poisonous species of snakes, scorpions,
honeybees, spiders and wasps are highly toxic and could cause various degrees of
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Child 10 94 28.2 1.41 11.2 2.10
Adult 60 1000 300 2.5 7.5 3.72
Table 2.
Calculated median lethal dose and effective dose 50 of honeybee venom and antivenom in human.
Figure 1.
Metalloproteinase of rattlesnake’s venom.
Figure 2.
Hyaluronidase of black mamba’s venom enzyme.
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Figure 3.
Eastern diamondback rattlesnake (Crotalus adamanteus) found in southeastern United States.
Figure 4.
Western diamondback rattlesnake (Crotalus atrox) can be found, from California to West Texas,
Oklahoma, the southern parts of New Mexico and Arizona and northern parts of Mexico. This species is also
found in several islands in the Gulf of California.
Figure 5.
Mojave rattlesnake (Crotalus scutulatus) found in the deserts of the southwestern United States and central
Mexico.
Figure 6.





Timber rattlesnake (Crotalus horridus) also commonly known as canebrake rattlesnake or banded
rattlesnake found in the eastern region of the United States.
Figure 8.
Pigmy rattlesnake (Sistrurus miliarius) found in the southeastern part of the United States.
Figure 9.
Massasauga rattlesnake (Sistrurus catenatus) found in several states of the United States, southern Ontario
in Canada and in northern Mexico on the border with Texas.
Figure 10.
Prairie rattlesnake or Great Plains rattlesnake (Crotalus viridis) found in the western United States. They
are also found in southwestern Canada and northern regions of Mexico.
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Figure 11.
Inland taipan (Oxyuranus microlepidotus) found in semi-arid regions of central east Australia.
Figure 12.
Coastal taipan also known as the common or eastern taipan (Oxyuranus scutellatus). It’s found throughout
the coastal regions of northern and eastern Australia and also on the island of New Guinea.
Figure 13.
Central Ranges taipan (Oxyuranus temporalis).
Figure 14.
King cobra (Ophiophagus hannah). King cobras live in Southeast Asia mainly in the plains and rainforests of




Monocled cobra (Naja kaouthia) can be found in China, India, Vietnam, Nepal, and Cambodia, but also
Malaysia, Bangladesh, Bhutan, Laos, Myanmar, and Thailand.
Figure 16.
Indian cobra (Naja naja). They are found in several countries including India, Pakistan, Sri Lanka,
Myanmar, southern Nepal, Bangladesh, Bhutan, and possibly in the extreme eastern Afghanistan in the Kabul
River Valley.
Figure 17.
Egyptian cobra (Naja haje) is found throughout most of North Africa north of the Sahara desert, and also
south of the Sahara through West Africa, in the Congo Basin, Kenya and Tanzania and the southern part of the
Arabian Peninsula.
Figure 18.
Mozambique spitting cobra (Naja mossambica)—eastern parts of southern Africa, most of Mozambique,
Swaziland, Zimbabwe, southern Angola, Zambia, Malawi, northeastern Namibia, northern Botswana, and
southern Tanzania including Pemba island.
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Figure 19.
Cape cobra (Naja nivea) found in southern Africa, particularly in South Africa and in parts of Botswana and
south part of Namibia.
Figure 20.
Common krait (Bungarus caeruleus) found in the Indian subcontinent. These snakes are found almost all
over Peninsular India but not in the offshore Islands. They are also found in other neighboring countries such as
Pakistan, Bangladesh, Nepal, and Sri Lanka.
Figure 21.
Blue krait is also known as theMalayan krait (Bungarus candidus). These snakes are found in Peninsular
Malaysia, central Vietnam,Thailand, Bali, Lao People’s Democratic Republic, Indonesia, Singapore, and Sumatra.
Figure 22.
Black mamba (Dendroaspis polylepis). The black mamba lives in the savannas and rocky hills of southern
and eastern Africa. Its fragmented range includes many African countries like the Democratic Republic of the
Congo, Sudan, Ethiopia, Eritrea, Somalia, Kenya, Uganda,Tanzania, Burundi, Rwanda, Angola,




4.1 Signs of ophidism
Difference between cobra and viper venom in terms of molecular weight, route
of administration and nature of toxin could account for differences in their venoms
Figure 23.
Eastern green mamba (Dendroaspis angusticeps). Their range stretches from the eastern Cape in South
Africa through Kenya, Mozambique,Tanzania, eastern Zimbabwe, and southern Malawi.
Figure 24.
Eastern gartersnake or Eastern garter snake(Thamnophis sirtalis sirtalis). They have a wide range across
eastern North America, extending as far north as southern Ontario and Quebec in Canada, to the Gulf of
Mexico in the south, along the eastern shores of America to the Mississippi River.
Figure 25.
California red-sided garter snake (Thamnophis sirtalis infernalis) found in California.
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lethality. Venom of Cerastes cerastes is more toxic than that of Bitis arietans and
Macrovipera lebetina and toxin of Naja haje is more toxic than that of C. cerastes, M.
lebetina and B. occitanus. Vipers have toxins with high molecular weight [25].
Therefore, venom quality has to be standardized for development of efficient anti-
venom, [26]. When the time of injected antivenom is shorter than fatal limit time,
Figure 26.
Checkered garter snake (Thamnophis marcianus) found in the southwestern United States southwards into
Mexico and Central America as far south as Costa Rica.
Figure 27.
Eastern brown snake (Pseudonaja textilis) found in the eastern half of Australia, except in Tasmania.
Figure 28.
King brown snake ormulga snake (Pseudechis australis) found over most of mainland Australia, except for
the extreme south and the southeast coastal regions.
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the envenomated may be protected by increasing the dose of antivenom. But when
the antivenom is injected closer to the fatal limit time, the chance of death is one-
half [27].
4.2 Treatment of snake envenomations
Rational dosage of snake antivenom requires larger randomized controlled trials
and further strategies are required to reduce morbidity in children bitten by Naja
atra [28]. Neurotoxic envenomations and complications thereafter correlate posi-
tively with snake antivenom dosage; hence higher doses are required which may
Figure 29.
Death adder (genus Acanthophis) found in Australia, Indonesia, New Guinea and its nearby islands.
Figure 30.
Red-bellied black snake (Pseudechis porphyriacus) native to eastern Australia. The red-bellied black snakes
are found in a more or less continuous range from southeastern Queensland south through eastern New South
Wales and Victoria.
Figure 31.
Gaboon viper (Bitis gabonica) found along the equatorial belt of Africa, East and Central Africa, and
southeast Africa. In the African Portuguese-speaking countries, it can be found in Guinea-Bissau, Angola, and
northern Mozambique.
Figure 32.
Tiger snake (Notechis) found in Australia.
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Figure 33.
Puff adder (Bitis arietans) found in African savannah and grasslands.
Figure 34.
Horned viper (Cerastes cerastes). It is found in many north African countries like Morocco, Mauritania,
Mali, eastward through Algeria, Niger,Tunisia, Libya and Egypt, Chad, Sudan, Ethiopia, Somalia, and
northern Israel.
Figure 35.
Boomslang (Dispholidus typus) found in sub-Saharan Africa in the central and southern regions of the
continent. The boomslang is most abundant in Botswana, Swaziland, Namibia, Mozambique, and Zimbabwe,
but the species has been reported as far north as southern Chad and Nigeria, and as far east as eastern Guinea.
Figure 36.
Rinkhals (Hemachatus haemachatus). The rinkhals is found in most provinces of South Africa, like western
and eastern Cape along the south coast, Mpumalanga, Free State, southern Gauteng and Kwazulu Natal.
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also cause adverse reactions [29]. Neutralization capacity of antivenom may be
related to geographic proximity of snake species [30]. Cerestes cerestes antivenom
and Macrovipera mauritanica antivenom cross react with Bitis arietans antivenom
due to presence of antigens common to them [31]. Tenerplasminin-1 (TP1), a
plasmin inhibitor isolated from Micrurus tener tener venom was similar to Kunitz-
type serine peptidase inhibitors [32]. Rauwolfia serpentina inhibits Daboia russelii
venom [33].
The therapeutic dose of antivenom is relative to the quantity of venom [34].
Therefore, postmortem lesions are required to provide the cause of death [35].
Figure 37.
Copperhead or water moccasin (Agkistrodon contortrix). These snakes are found in the United States and
in northern Mexico. In the USA, they are found in the states of Alabama, Arkansas, Florida, Georgia, Illinois,
Connecticut, Delaware, Indiana, Iowa, Kansas, Kentucky, Louisiana, Ohio, Mississippi, Missouri, Oklahoma,
Maryland, Massachusetts, New Jersey, New York, North Carolina,Tennessee,Texas, Pennsylvania, South
Carolina, Virginia, and West Virginia. In Mexico, it occurs in Coahuila and Chihuahua regions.
Figure 38.
Cottonmouth (Agkistrodon piscivorus) found in the southeastern United States.
Figure 39.
Mamushi or Japanese Mamushi (Gloydius blomhoffii) found in Japan, China, and Korea.
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Figure 40.
Russell’s viper (Daboia russelii) is found throughout Asia, in the Indian subcontinent, much of Southeast Asia
in southern parts of China and Taiwan. The species is found in many countries India, Pakistan, Sri Lanka,
Myanmar, Bangladesh, Nepal,Thailand, Cambodia, China,Taiwan, and Indonesia.
Figure 41.
Eyelash viper or eyelash palm-pit viper (Bothriechis schlegelii) found in central America and northern
South America.
Figure 42.
Golden lancehead (Bothrops insularis).
Figure 43.
Jararaca (Bothrops jararaca). They are found in southern Brazil, northeastern Paraguay, and Misiones
province in northern Argentina. It is also found in several islands off the coasts of Argentina and Paraguay, some
as far as 35 km offshore.
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Hence, neutralizing capacity of antivenins must be standardized [36] because of
complex nature of venom composition [37]. Pro-coagulant is used to assess anti-
venom activity and the results of antivenin test in rodents may not prove efficacious
in human [37] which is considered very important [38]. Hence, changes in dosing
Figure 44.
Fer-de-lance or terciopelo (Bothrops asper) inhabits the region from southern Mexico to northern South
America.
Figure 45.
Bushmaster (Lachesis muta) found in southern Central America and the northern half of South America
including the island of Trinidad.
Figure 46.
Mangrove snake (Boiga dendrophila) found in Indonesia, Malaysia,Thailand, Singapore, Vietnam,
Cambodia and Philippines.
Figure 47.
Ringneck snake (Diadophis punctatus) found in southeastern Canada and throughout most of the United
States southward into Central Mexico.
Figure 48.
European cat snake or European Catsnake (Telescopus fallax).
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Figure 49.
Indian red scorpion (Hottentotta tamulus) found throughout most of India, eastern Pakistan and the eastern
lowlands of Nepal.
Figure 50.
Deathstalker scorpion (Leiurus quinquestriatus). The deathstalker scorpion’s range covers a wide sweep of
territory in the Sahara, Arabian Desert,Thar Desert, and Central Asia, from Algeria and Mali in the west
through to Egypt, Ethiopia, Asia Minor and the Arabian Peninsula, eastward to Kazakhstan, and western
India.
Figure 51.
Arabian fat-tailed scorpion (Androctonus crassicauda) found mainly in the Palaearctic region. It is
commonly found in Saudi Arabia, Kuwait, Qatar, Iraq, Iran,Turkey, and in north African nations.
Figure 52.
Yellow fat-tailed scorpion (Androctonus australis). The yellow fat-tailed scorpion is found in north and
west Africa, the Middle East, and eastward to the Hindu Kush region. Countries where Androctonus species
live include Armenia, Morocco, Algeria,Tunisia, Libya, Egypt,Togo, Palestine, Israel, India, Lebanon,Turkey,




and development of new antivenins have been recommended [39]. However, low
effective dose can be used with beneficial results [40]. The most effective treatment
for snake envenomation is the specific heterologous serum [41] and additional dose
is unnecessary in brown snake envenomation [42]. Antivenom cause anaphylactic
Figure 53.
Black spitting thick-tailed scorpion (Parabuthus transvaalicus)—southern Africa.
Figure 54.
Striped bark scorpion (Centruroides vittatus) is distributed throughout the South-Central U.S. states and
throughout northern Mexico. Beginning in the northern Mexico Border States, Chihuahua, Coahuila, Nuevo
León, and Tamaulipas, C. vittatus’ range extends upward longitudinally through Texas, Oklahoma, and
Kansas, to reach as far north as Thayer County, Nebraska.
Figure 55.
Arizona bark scorpion (Centruroides exilicauda) found in the deserts of Arizona, California and Utah.
Figure 56.
Brazilian yellow scorpion (Tityus serrulatus)—South America.
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Figure 57.
Yellow-legged burrowing scorpion (Opistophthalmus glabrifrons)—southern Africa.
Figure 58.
Tanzanian red clawed scorpion (Pandinus cavimanus)—Tanzanian, Africa.
Figure 59.
Emperor scorpion (Pandinus imperator) found living in the rain forest or wet savannah, throughout Africa
from Mauritania to Zaire.
Figure 60.
Brown widow spider (Latrodectus geometricus) found throughout the world, including Africa, the United




Yellow sac spider (Cheiracanthium) is a species endemic to the Americas.
Figure 62.
Indian ornamental tarantula (Poecilotheria regalis) is a species of spider found in South Asia, as well as
southeastern India.
Figure 63.
Brown recluse (Loxosceles reclusa) primarily found in North America (throughout the Midwest and
Southern United States in particular).
Figure 64.
Black widow spider (Latrodectus) found on every continent of the world (with the exception of Antarctica).
19
Toxicosis of Snake, Scorpion, Honeybee, Spider, and Wasp Venoms: Part 1
DOI: http://dx.doi.org/10.5772/intechopen.92804
Figure 65.
Sydney funnel-web spider (Atrax robustus) is native to eastern Australia.
Figure 66.
Chinese bird spider (Cyriopagopus hainanus) is found predominantly in China and Southeast Asia.
Figure 67.
Redback spider (Latrodectus hasseltii) found predominantly in Australia, Southeast Asia, and New
Zealand.
Figure 68.




Six-eyed sand spider (Hexophthalma) is found predominantly in the deserts of southern Africa.
Figure 70.




Bald-faced hornet (Dolichovespula maculata) is found throughout North America.
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German yellowjacket Paravespula germanica (Linnaeus) found throughout North America.
Figure 75.
Paper wasps (Polistes species)—southern United States.
Figure 76.
Africanized honey bee (Apis mellifera scutellata Lepeletier) occurs naturally in sub-Saharan Africa but has
been introduced into the Americas.
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reactions [43] and serum sickness necessitating balance between treatment benefit
and the risk of adverse reactions [42]. Failure of snake antivenin may be due to the
fact that different snake venoms contain varieties of potent hemotoxins, neuro-
toxins, and other toxins [44]. Therefore, the viper venom is more toxic than elapine
venom due to the nature and molecular weight of toxins. Geographical variability,
the species of snakes, body weight, and the route of administration of antivenin are
very vital to successful treatment [45]. Toxins with molecular weight (<7KDa)
diffuse quickly into the blood stream [25], which may not affect efficacy of snake
antivenin IgY elevated by ion exchange chromatography [46].
But antivenin affects pharmacokinetic and pharmacodynamic properties of
venom. Hence, the quality of preparation and optimization of the use of antivenin
must be standardized [47]. The amount of antivenin is determined by clinical signs,
size of snake, and the known efficacy of available antivenin [9]. The route of
administration of antivenin is controversial, but intravenous route has been con-
sidered the most efficient [47]. Polyclonal antibodies are more effective against
Cerastes cerastes snake venoms in laying hens than in mammals [48]. Chicken
immunoglobulin (IgY) is more sensitive, easy to assay, does not activate human
complement system and does not react with human anti venomous IgG antibodies
or human Fc receptors [49]. The immunoglobulin IgY offers protection against
embryo infections [50]. The effective IgY dose required to prevent mortality in
rabbit was four times the dose of injected venom using Lowy’s protein assay [51].
Milk whey lactoferrin increased antibody levels and immune-stimulatory effects
against snake venom [52] whereas adjuvant sustains the release of antigen, interacts
with immune cells [53], activates nonspecific mediators of the immune system and
enhance macrophage phagocytic activity. IgG antibody neutralized activity against
T. albolabris venom [54]. Thai neuro polyvalent antivenin is considered second-line
treatment for Hydrophis schistosus and Hydrophis curtus [55]. Both IgG and F(ab0)2
antivenins activated human complement system with IgG having significantly
higher anti-complementary activity than F(ab0)2 antivenin [56]. Agkistrodon halys
antivenin is more efficacious than green pit viper antivenin [30]. Anti-Cc and Anti-
Mm F(ab0)2 cross reacted extensively with Bitis arietans venom, perhaps due to the
presence of venom antigens common to the both snakes [57]. Gamma irradiated
Naja haje antivenin showed higher neutralizing capacity [58]. Equine antivenom
neutralized coagulant and hemorrhagic activities against Rhabdophis tigrinus snake
venom [59]. Pseudo naja antivenin could not neutralize afbrinogenemia with serious
consequences [60]. Hence clotting factor replacement therapy using fresh frozen
plasma is associated with afibrinogenemia [61]. Gold nano-particle-based lateral
flow assay is used for detection of snake envenomation [62]. Therefore, pharmaco-
kinetics may be useful in design and optimization of antivenins [63]. Purification
and characterization of new bioactive compounds in snake venoms would be of help
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Hydrophis schistosus and Hydrophis curtus produce venoms that could be neutralized
by their neuropolyvalent antivenom (NPAV) and cross neutralization should serve
as basis for antivenom purification [55]. Non-irradiated and gamma-irradiated
polyvalent antivenoms could neutralize Naja haje [65]. Lack of potent monovalent
and polyvalent antivenins could be responsible for gross disparity in the manage-
ment of snakebite. Treatment of snake envenomation was introduced by Albert
Calmette of the Institute Pasteur Saigon in the 1890s. The antivenom is either whole
IgG or pepsin refined F(ab) fragments of IgG derived from plasma of horse, don-
key, mule, sheep immunized with venom of one or more species of snakes lyophi-
lized venoms that have shelf-life of about 5 years and should be stored at ≤250C,
whereas liquid antivenom have shelf-life of 2–3 years and should be stored at 2–8°C
and not frozen. Antivenoms against Naja naja, Bungarus caeruleus, Daboia russelli
and Echis carinatus are produced in India [66]. About 8–10 vials of antivenom
against Russell’s viper that injects 63 mg of venom is required. Each vial neutralizes
6 mg of the snake venom. Children should receive the same dose as adults, but
should be observed closely for antivenin post administration reaction. Normaliza-
tion of blood pressure in 15–30 minutes, stopping of coagulopathy in 6-hour, rever-
sal of neurotoxicity in 30 minutes and recovery within 24–48 hours are the
characteristics of effective snake antivenom. If there is coagulopathy, administra-
tion of anti-snake venom can be repeated every 6 hours or after 1–2 hours of the
initial dose. Worsening of cardiovascular signs requires repeating dose of snake
antivenom every 1–2 hours [67]. About 70% of all snakebites are by non-venomous
snakes and 50% of bites by venomous species are dry bites [68]. Serum produced
from irradiated Naja haje is more potent in venom neutralization than the serum
produced from native venom. The two sera inhibit cardiotoxic and hepatotoxic
effects [58]. Crescentia cujete fruit has significant neutralizing capacity against
Vipera russelli venom [69]. Snake envenomation detection immune assay (SEDIA)
is a potential diagnostic test for snake envenomation [52]. Milk whey (lactoferrin)
could be an adjuvant to snake antisera [52]. Pharmacokinetics of venom from
Hypnale hypnale are not changed by intramuscular injection of the venom, although
may reduce systemic bioavailability of the venom [63]. Structures, cytotoxicities,
and affinities to phospholipids of cytotoxins from the venom of Naja haje differ
[70]. Acorus calamus and Withania somnifera root extract have neutralizing poten-
tial against venom of Echis carinatus [71]. Isolated chicken immunoglobulin (IgY)
could neutralize viper venom [51]. Low dose snake antivenom with supportive
treatment is effective, less cost, and has low level of adverse reactions [72]. IgY
antibody could neutralize venom of Trimeresurus albolabris [54] and Cerestes cerestes
venoms [48]. Indian snake antivenoms (VINS and BHARAT) are effective against
D. russelli, E. carinatus, B. caeruleus and N. naja with VINS being more superior to
BHARAT [37]. Serum harvested from polyvalent venom from different species of
snakes could neutralize snake venom such as Rhabdophis tigrinus [59]. Too small
initial doses of snake antivenom could not neutralize venom of Pseudo naja; hence
the patient remains afribrinogenemic for long period of time [60]. Neutralizing
potential of snake antivenom (IgY) could be improved by ion exchange chroma-
tography. Therefore, IgG antivenom has significant complementary antivenom
activity than F(ab0)2 antivenom [56].
4.3 Medicinal plants and phytochemicals against ophidism
Andrographis paniculata and Aristolochia indica could neutralize venom of
Daboia russelli [41]. Higher dose of Haffkine polyvalent antivenom could neutralize
venom of Naja sumatrana [40]. Calotropis gigantea could neutralize venom of
Vipera russelli [73]. Brown snake, Pseudo naja causes venom induced consumption
24
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coagulopathy with over one-third of patients having serious hemorrhagic collapse
and microangiopathy. The venom is neutralized by one vial of antivenom [42].
Androctonus crassicauda antivenom could neutralize Mesobuthus venom found in
Aegean region of Turkey [74]. Lectins from Abrus precatorius may be tried against
snake and scorpion venoms. Because native and denatured agglutinin from the
plant has immunomodulatory potential [75]. Hence, clinical studies of the effec-
tiveness and safety of antivenoms have to be intensified because most currently
marketed antivenoms were registered without any formal clinical or preclinical
safety and effectiveness testing [76]. Change in amino acid sequence of a venom
component can lead to a change of new compounds. Alpha bungarotoxin is cholin-
ergic. Therefore, venom proteomics and genomics could lead to discovery of new
therapeutic agents including antivenoms [77]. Natural and synthetic inhibitors of
snake venom metalloproteinases are phenols and rosmarinic acid which inhibits
hemorrhage caused by venoms of Trimeresurus flavoviridis, Crotalus atrox and
Gloydius blomhoffii, Agkistrodon bilineatus, Deinagkistrodon acutus and Bitis arietans.
Apigenin also inhibits venom of Echis carinatus and gallic acid inhibits venom of
Daboia russelli, isoquercitrin, myricetin-B-O-glucoside and gallocatechin from
Schizolobium parahyba leaves neutralized venoms of Bothrops species including B.
jararacussu and B. alternatus [78, 79]. Matrix metalloproteinase inhibitors such as
that of zinc-binding group, marimastat, prinomastat and tanomastat inhibit venom
of Echis ocellatus. They are hydroxamic acid derivatives. Matrix metalloproteinases
are grouped as astacins, serralysins and reprolysins under metzincins [80, 81].
Zinc containing endopeptidases and calcium ions could be chelated by
ethylenediamine-tetraacetic acid, o-phenanthroline [82, 83], N,N,N,0N0-Tetrakis
(2-pyridylmethyl) ethane-1,2-diamine (TPEN), diethylene triamine pentaacetic
acid (DTPA), tetraethylthiuram disulfide (TID) in hemorrhage and myotoxicity
caused by venom of E. carinatus [84]. Bisphosphonate clodronate, tetracycline and
doxycydine inhibit hemorrhagic, proteolytic, coagulant and defibrigenotic effect of
venom from B. asper [85]. A clerodane diterpenoid from Baccharis trimera caused
inhibition of B. neuwiedi and B. jararacussu venoms [86]. Triacontyl p-coumarate
from Bombacopsis glabra inhibited venom of Bothropoides pauloensis, B. leucurus,
B. jararaca and B. pautoensis [87]. Macrolobin A and B (triterpnoid saponins) from
Pentaclethra macroloba inhibited venom of Bothrops [88]. Linearol and isolinearol
(secodolastane diterpenes) from Canistrocarpus cervicornis inhibited venom of B.
jararaca [89]. Lupeol and lupeol acetate (terpenes) inhibited E. carinatus-venom
induced damage [90]. Quinolones including 2-hydroxymethyl-6-methoxy-1,4-
dihydro-4-equinolinone inhibited venoms of B. jararacussu, B. moojeni and B.
alternatus [78]. N-acetyl cysteine inhibited gelatinase, hyaluronidase, hemorrhagic
and defribrinogenating activities of Vipera russelli and E. carinatus venoms [91].
A derivative of citalopram (DFD) neutralized venoms of E. carinatus, E. ocellatus,
E. carinatus sochureki, E. carinatus leakeyi and Crotalus atrox [92]. However, Allium
cepa, Securidaca longipedunculata, Carica papaya, Harrisonia abyssinica and
Nicotiana tobaccum are frequently used in treatment of snakebite. Low dose of
snake antivenom is highly cost-effective as compared to the high dose [92].
4.4 Signs of scorpionism
Scorpion species of medical importance are represented by the genera
Androctonus,Tityus, Mesobuthus, Hottentotta, Parabuthus, Centruroides and Leiurus.
Leiurus abdullahbayrami caused hyperexcitability, agitation, aggressiveness,
squeaking, fighting, tachypnea, weakness, convulsions and death due to cardiac and
respiratory failure [93]. Envenomation of Leiurus quinquestriatus showed degranu-
lation of eosinophils, fever, edema of cerebrum and myocarditis in rabbit [94].
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Tityus pachyurus polock envenomation was characterized by sialorrhea, respiratory
distress, profuse sweating, ataxia, restlessness, somnolence and hypoglycemia [95].
The toxicity of venom is relative to the maturity and weight of the scorpion [96].
Tityus stigmurus caused, cardiogenic shock, pulmonary edema, severe neurological
symptoms and death [9]. Spontaneous glycinergic and glutamatergic post synaptic
currents, suggest that scorpion toxin act on inhibitory and excitatory presynaptic
nerves. A. australis venom is more toxic followed by T. pachyurus, A. crassicauda, L.
quinquestriatus, M. eupeus, L. abdullahbayrami and H. sauleyi [93]. A. crassicauda
scorpion venom could induce activation of human monocytes leading to promotion
of expression of IL-12 [97] with molecular peptides (Acra 1 and Acra 2) that are
similar to known sodium-channel specific toxins of other scorpions [98]. M.
gibbosus endemic to Mediterranean area causes scorpionism characterized by pain,
pulsating and gloving sensations, cold, sweat, paleness, excitation, occasional spasm
of the affected part, tortuousness of the vein, which lasted for more than 4 years.
Periodical tingling, and occasional muscle twitches were observed during night. The
treatment was symptomatic [99].
4.5 Treatment of scorpionism
Local anesthetic is effective, while opioids are ineffective and increase the risk of
respiratory depression. Non-steroidal anti-inflammatory drugs may be disappoint-
ing. Bio 10 ml of 10% calcium gluconate administered over 5–10 minutes relieves
muscle pain and cramps and the effects last 20–30 minutes, hence safe limit dose is
required. SA IMR scorpion venom antiserum is equine anti-scorpion globulin sup-
plement in 5 ml per ampoule and 5–10 ml is required for adults and children. Its
plateau effect is achieved in 2–6 hours, hence respiratory support is of paramount
importance during the period. If case-response to first dose is inadequate, another
5 ml could be administered. The victim should be kept under close observation for
at least a period of 6–12 hours. Electrolytes, pH, acid-base balance arterial blood
gases, and electrocardiography should be used for assessment of scorpionism to
avoid fatality. The rule of thumb is that scorpions with thick tails and slender
pincers (e.g. Buthidae) produce more venoms than those with slender tails and large
pincers. Hence speed of scorpion and a wave of potential neurotoxic effects are very
important. Bioclon and Butantan are very effective antivenins against scorpionism
[95]. Treatment of scorpion envenomation requires specific antiserum. Antiserum
against Buthus quinquestriatus from immunization of horses with crude venom as
antigen has been proven to be effective [100], and high amount of antivenins is
required to achieve satisfactory neutralization [101]. A. crassicauda antivenin could
prevent, neutralize and cure M. eupeus scorpionism if applied at optimum time,
dose, and route [102]. The LD50 of A. crassicauda venom (1.1 mg/kg) and 39.19 mg/
kg [103] make it highly toxic. The long half-life of venom in the body might require
antivenin that has long half-life [101].
In Saudi Arabia, scorpionism is treated using 5 ml of antivenom diluted in 5–20 ml
of saline and the solution was administered intravenously. Adjunct chemotherapy
could be instituted when required. However, a 12-year-old boy inadequately treated
with antivenom died from pulmonary edema, hematemesis, severe neurotoxicity,
and circulatory failure. All the patients treated in Saudi Arabia stayed in hospitals for
1–2 days. The incidence of antivenom reaction was 1.7–6.6%, low protein level of
antivenom, and high quality of catecholamine could lead to antivenom failure [101].
Two purified toxic fractions of Mesobuthus eupeus toxin were quickly eliminated
from tissue [104] signifying that M. eupeus toxicity may not last long in the body.
Dissociation of the toxin-channel complex during depolarization is determined by
the difference between electrical energies of the activated states of normal and
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toxin-modified channels [105]. The partially purified toxic fractions, when injected
to rabbits, gave rise to more potent antivenoms against whole venoms as compared
to presently commercially available antivenoms [106]. A. crassicauda has LD50 of
venom (15.45 μg/kg) in mice, making it one of the highly toxic species of scorpions
in the world [103]. A. crassicauda antivenom could neutralize M. gibbosus venom
(20 LD50) in Aegean region of Turkey [107]. Thus, highly potent antivenom could
be produced from about 238 telsons in 51 days [74].
Comparing the calculated ratio of 29213:6 and
330
13:6 which gives equivalent weight of
21.5 kg and 24.3 kg respectively shows that Butantan (292 μg/ml) and Bioclon
(330 μg/ml) can be used effectively in the treatment of human weighing 21.5 and
24.3 kg body weight, respectively. Signifying that age plays role on the disposition
of Tityus toxin, the toxic principle of Tityus species. Therefore, the difference in
severity of symptoms observed in children and adults may be due to difference in
pharmacokinetics of the toxin. Mesobuthus eupeus venom can be neutralized by
nanovalent, polyvalent and anti-idiotype antivenom, respectively. They are non-
toxicants and can be used as a vaccine in people at the risk of scorpion stings [108].
Scorpion anti-venoms are specific antigens, detoxified venoms or toxins, purified
venom fractions, natural toxoids, recombinant toxins, synthetic peptides, mono-
clonal and recombinant antibodies [100]. Using peptides derived from the sequence
of scorpion toxins, the penetration of antipeptide antibodies can neutralize the
cognate venom [109]. Turkish antivenom against A. crassicauda is effective against
other species of scorpions. Minimum lethal dose and minimum effective dose were
used to evaluate the effect of Turkish antivenom on M. gibbosus envenomation [96]
suggesting applicability of the new formula for calculation of effective dose for
antivenoms. Scorpion sting results in adult morbidity and pediatric mortality [110].
The most lethal species are T. serrulatus,T. bahiensis in Brazil, Centruroides suffusus,
C. lionpidus, C. sculpturatus in Mexico, Leiurus quinquestriatus, A. crassicauda, A.
australis, A. amoreuni, Buthus occitanus in Middle East and North Africa, Parabuthus
grauntatus and P. transvaalicus in South Africa, Mesobuthus tamulus and Palamneus
swammerdance in India [111], respectively. One milliliter of Androctonus crassicauda
antivenom could neutralize Mesobuthus eupeus venom. The antivenom is monova-
lent with immune activity and neutralizing capacity. The venom is produced by
Refik Saydam Hygiene Centre in Turkey [103]. Also A. crassicauda antivenom could
neutralize Mesobuthus gibbosus venom [96]. Stings from Leiurus abdullahbayrami
causes hyperexcitability, agitation, aggressive behavior, squeaking, fighting,
tachypnea, weakness, convulsions, and death due to cardiorespiratory failure.
However, the venom has two kinds of protein with molecular masses of 4 and
6 kDa, respectively [93]. The condition was treated by dipping the affected hand in
ice water, adrenaline (1:1000) was injected around the site of the sting and chlor-
pheniramine was injected intramuscularly into the upper arm. Snake antivenom
made by J. Wyeth and Brother Ltd., Canada was administered intramuscularly [112]
and produced desired therapeutic effect against scorpionism. Scorpion envenom-
ation may be more dangerous in pregnant woman [113]. However, Meu TxKα3, a
scorpion toxin-like peptide could undergo mutation at site 30 and help improve its
K+ channel-blocking and antibacterial function [114]. The designed bispecific
NbF12–10 neutralized AahI and AahII toxins and could be used in the treatment of
Androctonus australis envenomation. About 100-kDa horse antivenom serum could
neutralize 7 kDa scorpion toxin and 15 kDa antivenom could neutralize AahI toxin.
The NbAch10 F12 fully neutralized 100 LD50 of AahI toxin [115]. Children with
abnormal electrocardiography may require high dose of antivenom [116].
Aminotoxin could activate T lymphocytes and may be used as immunomodulators
in infection and cancer [117] whereas Ca2+-activated K+ channel (ISK2) is sensitive
to apamin [118]. Nevertheless alpha-KTx peptides from the venom of Centruroides
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elegans block Kv1.3 of T lymphocytes [119] whereas Tst26 peptide from T. stigmurus
block Kv1.2 and Kv1.3 channels [120] respectively. T. serrulatus could be detected
using molecular mass of the venom [121]. Androctonus mauretanicus mauretanicus
toxin could cross-react with the serum of Androctonus australis [122]. Androctonus
mauretanicus and Buthus occitanus contain mycotoxins and post synaptic neuro-
toxins with the first being more toxic. But the polyclonal antivenom prevented
lethality from A. mauretanicus, B. occitanus and A. crassicauda venoms [123]. Venom
of A. mauretanicus is more toxic than that of A. australis hector that is more toxic
than that of B. occitanus. Lethality of scorpion venom in mammals is dependent on
age and species of the animals [124]. That is why the pharmacokinetics of a Tityus
toxin from T. serrulatus scorpion venom is dependent on the age of affected indi-
viduals [125]. Death due to scorpionism is secondary to cardiorespiratory failure
[126]. Hence quick detection and quantification of venom is necessary for rational
therapy, which is highly beneficial to reduce management costs and patients risk
[127]. Equine F(ab0)2, IgG recombinant toxin, synthetic apitoxin, mAb, Fab, ScFv,
chFab and rFab are of great benefit in treatment of scorpion and spider enveno-
mation [128]. Minimum effective dose of antivenom is administered precociously
by intravenous route to achieve efficient immunotherapy [129].
A. australis has complex venom that contains cytotoxic principles with very fast
resultant fatal effects [130]. The effective monoclonal antibodies (mAbs) specific
for the α-neurotoxin 1 (Aah1) from A. australis hector venom has been reported
[131]. A. australis has recombinant toxin II with immunological and biological
properties [132]. In addition, Androctonus australis hector (Aah) envenomation is
mediated by cytokines and complement system, which in turn activate leukocyte to
damage tissue [133]. But kinins are involved in cardiovascular toxicity and lethality
of L. quinquestriatus venom in rabbits. Androctonus australis garzonii venom
(100 μg/kg) was neutralized by 4 mg/kg of antivenom injected intravenously [128].
Antivenoms against a number of scorpion venoms have been reported [127],
suggesting that the potency of antivenom should be investigated in relation to the
scorpion venom [93] and both LD50 and ED50 should be determined paradoxically
and canonically [134].
Intravenous LD50 of Vipera berus berus (0.4 μg/kg) with signs including head-
drop, floppy neck, flaccid paralysis of limb, respiratory paralysis and death [135]
and that of Laticauda colubrine, 0.05–0.13 μg/g [136], Sri Lankan B. caeruleus
0.07 μg/g [137], and Naja sputatrix [138] disagree with the reported LD50 (0.5 ng)
of Androctonus australis [93] signifying that the venom of V. berus berus is less
potent than with that of A. australis. Similar signs were observed for V. nikolskii
venom (1.0 μg/kg) but the signs caused by phospholipase A2 were lost after the
mice were injected strontium [139], which may become antivenom against V. berus
berus and A. australis venoms in future. The newly developed dot-ELISA for detec-
tion of venoms of Indian venomous snakes, Naja naja, Bungarus caeruleus, Daboia
russelli and Echis carinatus [140] with comparative proteomic enzymes [141] may be
also used to detect scorpion venoms. High level of toxicity ofMontivipera raddei and
Montivipera bubjardahica venoms is responsible for, high activity against A549
human lung carcinoma [142] signifying that scorpion venom may have anticancer
activity. Lethal doses of L. quinquestriatus were 0.5 mg/kg i.v. and 3 μg/kg i.m.
[143]. The LD50 of T. pachyurus venom in monogastric animals show that mouse
(4.8 μg/kg) is highly sensitive to T. pachyurus venom, Hamster (3.48 μg/kg), guinea
pig (2.40 μg/kg), rat (2.32 μg/kg), rabbit (1.16 μg/kg), monkey (1.11 μg/kg), mar-
moset (2.40 μg/kg), squirrel monkey (2.08 μg/kg), ferret (1.99 μg/kg), cat (0.74 μg/
kg), dog and baboon (0.70 μg/kg), child (0.56 μg/kg), micro pig (0.52 μg/kg), mini
pig (0.40 μg/kg) and adult human (0.37 mg/kg) respectively [103] indicating that
Tityus pachyurus toxin is more toxic to all the species of animals [139] as compared
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to American pit viper venom [144]. The toxicity may be due to the presence of
Tityus toxins that are also present in Tityus pachyurus,T. stigmurus,Tityus obscurus
and Tityus serrulatus venom. The toxic principle acts via Na+, K+, Ca2+ and Cl
channels signifying excitatory effects on heart, CNS and muscular fibers [142].
Hence, mini pig could be the best model for determination of LD50 and ED50 for T.
pachyurus venom and antivenom respectively for human application [103].
5. Conclusion
The toxicity of snake and scorpion venom is dependent on the quantity of the
venom, whereas apitoxicosis in human is dependent on the number of stings and
dose of venom produced per sting. Snake and scorpion venoms are the most dan-
gerous. However, venoms of some snakes and scorpions are equipotent and require
2 or more vials of antivenoms. LD50 of honeybee venom in adult man is 2.5 mg/kg
which can be neutralized by 7.5 mg/kg (3LD50) of antivenin. LD50 of honeybee
venom in child is 1.41 mg/kg and can be neutralized by 11.2 mg/kg (7.9LD50)
antivenin. The venom can kill in less than 4 hours. Hence, children are more
sensitive to honeybee toxicity than the adults are, and so may require higher dose of
antivenom. Spider and wasp envenomation are less severe and could be treated
symptomatically. All the organ systems could be affected and complications could
follow multiple attacks. Hence treatment is by administration of antivenins, anti-
inflammatory, analgesic and respiratory support. Neurological and cardiorespira-
tory signs may be considered as indices of therapeutic success or failure. Prompt
therapeutic intervention and hospitalization of 1 or more days could either delay or
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